Pfizer Will Ask U.S. FDA for Approval of Its “Vaccines” for Six Months – Two Year-Olds (Children Under 10 Don’t Even Have Flu Receptors)

uTN Social - Free Speech Social Media

Child murderers. They know.


Quick note: Tech giants are shutting us down. You know this. Twitter, LinkedIn, Google Adsense, Pinterest permanently banned us. Facebook, Google search et al have shadow-banned, suspended and deleted us from your news feeds. They are disappearing us. But we are here. We will not waver. We will not tire. We will not falter, and we will not fail. Freedom will prevail.



Subscribe to Geller Report newsletter here — it’s free and it’s critical NOW when informed decision making and opinion is essential to America’s survival. Share our posts on your social channels and with your email contacts. Fight the great fight.




Follow me on Gettr. I am there, click here. It’s open and free.

Remember, YOU make the work possible. If you can, please contribute to Geller Report.

Pfizer CEO says company will ask for FDA approval of its COVID vaccine for children aged 5-11 ‘in days’

Pfizer Inc’s CEO Albert Bourla appeared on Sunday on ABC’s This Week

By: Daily Mail, September 28, 2021:

He said the company will submit its application for FDA approval of its Covid vaccine in children aged 5-11 ‘in days’
Recently released data showed the vaccine induced a ‘robust’ immune response in younger kids, Pfizer said
Kids aged 5-11 will receive smaller doses at 10 micrograms (μg) given 21 days apart compared to the 30 μg doses for those aged 12 and older
Parents are split 50/50 over whether or not to vaccinate their kids because children make up less than 0.1% of all Covid deaths in the U.S.

Pfizer‘s CEO says the company plans to ask the U.S. Food and Drug Administration (FDA) for authorization of its COVID-19 vaccine in younger children ‘in days.’

On Sunday, in an appearance on ABC’s This Week, Albert Bourla was asked when the country should expect the shots to be approved in kids between ages five and 11.

The New York-based firm, along with its German partner BioNTech, recently released data that it said showed the vaccine was safe and effective in a smaller doses in elementary schoolers.

Pfizer‘s CEO says the company plans to ask the U.S. Food and Drug Administration (FDA) for authorization of its COVID-19 vaccine in younger children ‘in days.’

On Sunday, in an appearance on ABC’s This Week, Albert Bourla was asked when the country should expect the shots to be approved in kids between ages five and 11.

The New York-based firm, along with its German partner BioNTech, recently released data that it said showed the vaccine was safe and effective in a smaller doses in elementary schoolers.

Albert Bourla, Pfizer’s CEO, who talked about “annual re-vaccinations” against Covid, is looking to go one step further by asking the U.S. Food and Drug Administration (FDA) “in days” to authorise the use of its vaccine in even younger children.

On ABC’s This Week, Albert Bourla was asked when the country should expect the shots to be approved in children between ages five and 11. Pfizer/BioNTech, released data that it said showed the vaccine was safe and effective in a smaller doses in elementary schoolers. “I think we are going to submit this data pretty soon,” Bourla told host George Stephanopoulos. “It’s a question of days, not weeks, and then it is up to FDA to be able to review the data and come to their conclusions and approve it or not.”

According to clinicaltrials.gov, Pfizer’s study in younger children worked similarly to the way it did in older children and adults. 4,500 children from ages six months to 11 years were enrolled at nearly 100 clinical trial sites in 26 U.S. states, Finland, Poland and Spain. Half of the ages five-to-11 group were given two doses 21 days apart and the other half were given placebo shots. The team then tested the safety, tolerability and immune response generated by the vaccine by measuring antibody levels in the children.

Pfizer said it had selected lower doses for Covid vaccine trials in children than are given to teenagers and adults. Bourla said Pfizer would be ready to ship these smaller doses across the country if the FDA authorises the shot in younger children.

Unlike the larger clinical trial conducted in adults, the pediatric trial did not measure efficacy by comparing the number of Covid cases among the vaccine group to the number in the placebo group. Instead, scientists looked at levels of neutralizing antibodies in young vaccine recipients and compared the levels to those seen in adults. (Why do you suppose they did it that way? Because children under 10 are already completely immune from Covid and every other type of flu, and everyone in Pfizer knows it, so they had to change the tests to fraudulently pretend that children are somehow going to immunized by their monkey gunk concoction against something from which they are already immune. And by the way, I am still waiting for someone to explain how a six-month-old baby is supposed to give its “informed consent.”)

The companies expect data on how well the vaccine works in children between ages two and five and between six months and two years of age by the end of December.

https://abcnews.go.com/Politics/pfizer-ceo-distribute-boosters-primary-doses/story?id=80232565

https://www.dailymail.co.uk/health/article-10033291/Pfizer-CEO-says-firm-ask-FDA-approval-COVID-19-vaccine-children-aged-5-11-days.html

Have a tip we should know? Your anonymity is NEVER compromised. Email tips@thegellerreport.com

The Truth Must be Told

Your contribution supports independent journalism

Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won’t get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won’t put up a paywall. Because never has the free world needed independent journalism more.

Everyone who reads our reporting knows the Geller Report covers the news the media won’t. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left’s war on freedom. Our readers’ contributions make that possible.

Geller Report’s independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.

Please contribute here.

Make a monthly commitment to support The Geller Report – choose the option that suits you best.

Read More Feedzy

The Foxhole App - Trusted News Podcasts

Leave a Reply

Your email address will not be published. Required fields are marked *